On October 29, 1999, WLF filed a brief urging the U.S. Court of Appeals for the D.C. Circuit to set aside an order by the Federal Trade Commission (FTC) compelling Novartis Corporation, a pharmaceutical company, to include a governmentally-dictated message in its advertising. The FTC filed a complaint against Novartis, the manufacturer of Doan’s Pills, alleging that advertisements for Doan’s had been misleading insofar as they suggested that Doan’s offers more effective relief for back pain than other pain relievers. After an independent review, WLF urged that the court of appeals would find no factual basis on which to conclude that corrective advertising was warranted.
